Windtree Therapeutics (NASDAQ:WINT – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($20.91) earnings per share (EPS) for the quarter, missing the consensus estimate of ($8.11) by ($12.80), Zacks reports.
Windtree Therapeutics Stock Up 2.0 %
Windtree Therapeutics stock opened at $11.22 on Wednesday. Windtree Therapeutics has a 52-week low of $2.81 and a 52-week high of $27.00. The firm has a market cap of $6.64 million, a PE ratio of -0.31 and a beta of 0.55. The company’s 50 day moving average is $5.81 and its two-hundred day moving average is $5.71.
Windtree Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Windtree Therapeutics
- Earnings Per Share Calculator: How to Calculate EPS
- Can Visa Capitalize on Surging Record Credit Card Debt Levels?
- 5 discounted opportunities for dividend growth investors
- Doximity: The ‘Facebook for Doctors’ Surges After Earnings Beat
- Investing In Preferred Stock vs. Common Stock
- Value Investing: Unearthing 3 Hidden Gems in Today’s Market
Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.